PriceTargets.com logo

Cryo-Cell International - CCEL Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$7.83 As of 12/20/2024 05:32 PM ET
▼ -0.07 (-0.89%)

This chart shows the closing price for CCEL by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cryo-Cell International Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CCEL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CCEL

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Cryo-Cell International in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $7.83.

This chart shows the closing price for CCEL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in Cryo-Cell International. This rating has held steady since August 2023, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/2/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/28/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/23/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/23/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/29/2022Maxim GroupInitiated CoverageBuy$12.00
(Data available from 12/23/2019 forward)

News Sentiment Rating

1.53 (Strong Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/27/2024
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/26/2024
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/26/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/24/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/24/2024
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/23/2024
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/23/2024

Current Sentiment

  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

Cryo-Cell International logo
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Read More

Today's Range

Now: $7.83
Low: $7.68
High: $7.85

50 Day Range

MA: N/A

52 Week Range

Now: $7.83
Low: $4.47
High: $9.50

Volume

5,450 shs

Average Volume

11,103 shs

Market Capitalization

$63.11 million

P/E Ratio

N/A

Dividend Yield

12.21%

Beta

0.49

Frequently Asked Questions

What sell-side analysts currently cover shares of Cryo-Cell International?

The following Wall Street research analysts have issued reports on Cryo-Cell International in the last twelve months:
View the latest analyst ratings for CCEL.

What is the current price target for Cryo-Cell International?

0 Wall Street analysts have set twelve-month price targets for Cryo-Cell International in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Cryo-Cell International in the next year.
View the latest price targets for CCEL.

What is the current consensus analyst rating for Cryo-Cell International?

Cryo-Cell International currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for CCEL.

What other companies compete with Cryo-Cell International?

Other companies that are similar to Cryo-Cell International include LifeMD, Biodesix, EUDA Health, Quipt Home Medical and Exagen. Learn More about companies similar to Cryo-Cell International.

How do I contact Cryo-Cell International's investor relations team?

Cryo-Cell International's physical mailing address is 700 Brooker Creek Boulevard Suite 1800, Oldsmar FL, 34677. The company's listed phone number is (813) 749-2100 and its investor relations email address is [email protected]. The official website for Cryo-Cell International is www.cryo-cell.com. Learn More about contacing Cryo-Cell International investor relations.